Evidence map›Paper›PMID 41385099›Full record

ReviewZeitschrift fur Rheumatologie2026

[Juvenile idiopathic arthritis-persistent oligoarticular subtype : Consensus-based treatment recommendations as part of the ProKind Rheuma Initiative].

Joachim Peitz, Gerd Horneff, Anna Raab, Hanna Winowski, Sandra Hansmann, Klaus Tenbrock, Kommission Pro-Kind der Gesellschaft für Kinder- und Jugendrheumatologie

Abstract readConsensus StatementEnglish AbstractReview
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joachim PeitzKinderrheumazentrum, Sankt Augustin, Zentrum für Allgemein Pädiatrie und Neonatologie, Asklepios Klinik Sankt Augustin, Sankt Augustin, Deutschland.
Gerd HorneffKinderrheumazentrum, Sankt Augustin, Zentrum für Allgemein Pädiatrie und Neonatologie, Asklepios Klinik Sankt Augustin, Sankt Augustin, Deutschland.
Anna RaabKlinik für pädiatrische Pneumologie, Allergologie und Neonatologie, Abteilung Pädiatrische Rheumatologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
Hanna WinowskiKlinik für Kinder- und Jugendrheumatologie, St. Josef Stift Sendenhorst, Sendenhorst, Deutschland.
Sandra HansmannKlinik für Kinder- und Jugendmedizin, Abteilung III, Universitätsklinikum Tübingen, Tübingen, Deutschland.
Klaus TenbrockKlinik für Kinder- und Jugendmedizin, Translationale Pädiatrische Rheumatologie und Immunologie, Klinikum der RWTH Aachen, Pauwelsstr 30, 52074, Aachen, Deutschland. ktenbrock@ukaachen.de.
Kommission Pro-Kind der Gesellschaft für Kinder- und Jugendrheumatologie

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protocols concerning classification, monitoring and treatment were developed for the oligoarticular form of juvenile idiopathic arthritis (JIA) as part of a consensus process. The group of authors formulated 23 statements and circulated them in an online survey to medical members of the Society for Paediatric and Adolescent Rheumatology (GKJR). A total of 80 of the 124 paediatric and adolescent rheumatologists took part in the survey, which corresponds to just under 65% of the paediatric and adolescent rheumatologists who were active at the time. In a final online meeting, comments from the survey were incorporated into the statements and then agreed upon by the group of authors. For newly occurring oligoarticular JIA, 20 statements and a summary consensus treatment protocol were developed to optimise the treatment of persistent oligoarticular JIA.

Indexed as

Antirheumatic AgentsArthritis, JuvenileRheumatologyAdolescentChildEvidence-Based MedicineGermanyHumansTreatment OutcomeAntirheumatic AgentsIntra-articular injectionsMethotrexateOff-label usePediatric rheumatologyTreat-to-target management

Identifiers

PMID41385099
PMCPMC12872668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.